Global Custom Market Research Reports Provider Company

phone

France Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Published Date: 01 Aug 2017
  • Number of Pages: 158
  • Category: Healthcare and Medical
  • Country: France
France Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

GlobalDatas new report, "France Drug Delivery Devices Market Outlook to 2023", provides key market data on the France Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the France Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.
Publisher Name : GlobalData

2 Introduction 7
2.1 What Is This Report About? 7
2.2 Drug Delivery Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Drug Delivery Devices Market, France 11
3.1 Drug Delivery Devices Market, France, Revenue ($m), 2009-2023 11
3.2 Drug Delivery Devices Market, France, Revenue Mix ($m), 2016 13
3.3 Drug Delivery Devices Market, France, Category Contribution by Revenue ($m), 2016 14
3.4 Drug Delivery Devices Market, France, Category Comparison by Revenue ($m), 2009-2023 15
3.5 Drug Delivery Devices Market, France, Revenue ($m), 2009-2016 16
3.6 Drug Delivery Devices Market, France, Revenue ($m), 2016-2023 18
3.7 Drug Delivery Devices Market, France, Volume (Units), 2009-2023 20
3.8 Drug Delivery Devices Market, France, Volume (Units), 2009-2016 22
3.9 Drug Delivery Devices Market, France, Volume (Units), 2016-2023 24
3.10 Drug Delivery Devices Market, France, Company Share by Revenue ($m), 2016 26
4 Central Venous Catheters Market, France 28
4.1 Central Venous Catheters Market, France, Revenue Mix ($m), 2016 28
4.2 Central Venous Catheters Market, France, Segment Contribution (%), 2016 29
4.3 Central Venous Catheters Market, France, Revenue ($m), 2009-2016 30
4.4 Central Venous Catheters Market, France, Revenue ($m), 2016-2023 32
4.5 Central Venous Catheters Market, France, Volume (Units), 2009-2016 34
4.6 Central Venous Catheters Market, France, Volume (Units), 2016-2023 36
4.7 Central Venous Catheters Market, France, Distribution Share by Revenue ($m), 2015-2016 38
4.8 Central Venous Catheters Market, France, Company Share by Revenue ($m), 2016 39
5 Infusion Systems Market, France 41
5.1 Infusion Systems Market, France, Revenue Mix ($m), 2016 41
5.2 Infusion Systems Market, France, Segment Contribution (%), 2016 42
5.3 Infusion Systems Market, France, Revenue ($m), 2009-2016 43
5.4 Infusion Systems Market, France, Revenue ($m), 2016-2023 45
5.4.1 Ambulatory Infusion Pumps Market, France, Revenue ($m), by Segment, 2009-2016 47
5.4.2 Syringe Pumps Market, France, Revenue ($m), by Segment, 2009-2016 49
5.4.3 Ambulatory Infusion Pumps Market, France, Revenue ($m), by Segment, 2016-2023 51
5.4.4 Syringe Pumps Market, France, Revenue ($m), by Segment, 2016-2023 53
5.5 Infusion Systems Market, France, Volume (Units), 2009-2016 55
5.6 Infusion Systems Market, France, Volume (Units), 2016-2023 57
5.6.1 Ambulatory Infusion Pumps Market, France, Volume (Units), by Segment, 2009-2016 59
5.6.2 Syringe Pumps Market, France, Volume (Units), by Segment, 2009-2016 61
5.6.3 Ambulatory Infusion Pumps Market, France, Volume (Units), by Segment, 2016-2023 63
5.6.4 Syringe Pumps Market, France, Volume (Units), by Segment, 2016-2023 65
5.7 Infusion Systems Market, France, Distribution Share by Revenue ($m), 2015-2016 67
5.8 Infusion Systems Market, France, Company Share by Revenue ($m), 2016 68
6 Metered Dose Inhaler Devices Market, France 70
6.1 Metered Dose Inhaler Devices Market, France, Revenue ($m), 2009-2016 70
6.2 Metered Dose Inhaler Devices Market, France, Revenue ($m), 2016-2023 71
6.3 Metered Dose Inhaler Devices Market, France, Volume (Units), 2009-2016 72
6.4 Metered Dose Inhaler Devices Market, France, Volume (Units), 2016-2023 73
6.5 Metered Dose Inhaler Devices Market, France, Distribution Share by Revenue ($m), 2015-2016 74
6.6 Metered Dose Inhaler Devices Market, France, Company Share by Revenue ($m), 2016 75
7 Needle Free Injections Market, France 77
7.1 Needle Free Injections Market, France, Revenue ($m), 2009-2016 77
7.2 Needle Free Injections Market, France, Revenue ($m), 2016-2023 78
7.3 Needle Free Injections Market, France, Volume (Units), 2009-2016 79
7.4 Needle Free Injections Market, France, Volume (Units), 2016-2023 80
7.5 Needle Free Injections Market, France, Distribution Share by Revenue ($m), 2015-2016 81
7.6 Needle Free Injections Market, France, Company Share by Revenue ($m), 2016 82
8 Overview of Key Companies in France, Drug Delivery Devices Market 84
8.1 B. Braun Melsungen AG 84
8.1.1 Company Overview 84
8.2 GlaxoSmithKline Plc 84
8.2.1 Company Overview 84
8.3 Baxter International Inc 84
8.3.1 Company Overview 84
8.4 AstraZeneca Plc 84
8.4.1 Company Overview 84
8.5 Becton Dickinson and Co 85
8.5.1 Company Overview 85
8.6 Boehringer Ingelheim GmbH 85
8.6.1 Company Overview 85
8.7 Fresenius Kabi AG 85
8.7.1 Company Overview 85
8.8 Pfizer Inc 85
8.8.1 Company Overview 85
8.9 Merck & Co Inc 86
8.9.1 Company Overview 86
8.10 Medtronic Plc 86
8.10.1 Company Overview 86
8.11 Smiths Medical 86
8.11.1 Company Overview 86
8.12 Terumo Corp 86
8.12.1 Company Overview 86
8.13 Hospira Inc 87
8.13.1 Company Overview 87
9 Drug Delivery Devices Market Pipeline Products 88
10 Financial Deals Landscape 93
10.1 Asset Transactions 93
10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 93
10.2 Partnerships 95
10.2.1 Alimera Sciences Enters into Licensing Agreement with pSivida 95
10.2.2 Bluegrass Vascular Enters into Partnership with Merit Medical 96
10.2.3 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 97
10.2.4 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 98
10.2.5 Propeller Health Enters into Agreement with Novartis Pharma 100
10.2.6 Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology 101
10.2.7 Pfizer Terminates its Licensing Agreement with pSivida 102
10.2.8 Biocorp Production Enters into Licensing Agreement 103
10.2.9 Bayer Enters into Licensing Agreement with DelSiTech 104
10.2.10 BioCorRx Enters into Licensing Agreement with Therakine 105
11 Recent Developments 106
11.1 Corporate Communications 106
11.1.1 Jun 28, 2017: Cellectis Appoints Rainer Boehm, M.D. and Herve Hoppenot to Board of Directors 106
11.1.2 Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia 106
11.1.3 Apr 11, 2017: Sanofi Announces Pre-quarterly Results Communication 107
11.1.4 Apr 05, 2017: Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee 108
11.1.5 Mar 30, 2017: Avadel Pharmaceuticals Announces Planned Reduction of French Workforce 108
11.1.6 Mar 06, 2017: EDAP Appoints Vice-President of Global Medical, Regulatory and Quality Affairs in the US 108
11.1.7 Mar 02, 2017: Sanofis Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charles as New Independent Directors 109
11.1.8 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK 109
11.1.9 Jan 30, 2017: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs 110
11.1.10 Jan 03, 2017: Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Commercial Officer 110
11.1.11 Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare 111
11.1.12 Sep 07, 2016: Sanofi Appoints New Research Head for Immunology and Inflammation 111
11.1.13 Sep 06, 2016: Sanofi Board Of Directors Provides Update 112
11.2 Financial Announcements 112
11.2.1 Jul 12, 2017: Sanofi: Pre-quarterly Results Communication 112
11.2.2 May 17, 2017: EDAP TMS SA Reports First Quarter 2017 Results 113
11.2.3 May 09, 2017: Cellectis Reports 1st Quarter 2017 Financial Results 113
11.2.4 May 09, 2017: Avadel Pharmaceuticals Reports First Quarter 2017 Results 115
11.2.5 Apr 28, 2017: Sanofi Delivers Robust Q1 2017 Financial Results 116
11.2.6 Apr 03, 2017: EDAP Achieves 63% Growth in HIFU Revenue in 2016 121
11.2.7 Mar 07, 2017: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results 122
11.2.8 Mar 06, 2017: Cellectis Reports 4th Quarter and Full Year 2016 Financial Results 123
11.2.9 Feb 23, 2017: EDAP Announces Preliminary Unaudited Full Year 2016 Revenue 125
11.2.10 Feb 08, 2017: Sanofi Delivers 2016 Sales and Business EPS Growth at CER 125
11.2.11 Nov 22, 2016: Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2016 132
11.2.12 Nov 17, 2016: EDAP Achieves 79% Growth in HIFU Revenue for First Nine Months of 2016 135
11.2.13 Nov 07, 2016: Flamel Technologies Reports Third Quarter 2016 Results 135
11.2.14 Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results 136
11.2.15 Sep 08, 2016: Cellectis Reports 2nd Quarter and First Half Year 2016 Financial Results 142
11.2.16 Aug 25, 2016: EDAP Reports 69% Growth in HIFU Revenues and Operating Profit for First Half 2016 144
11.2.17 Jul 29, 2016: Sanofi Announces Q2 2016 Results 145
11.2.18 Jul 29, 2016: Royalty report for Q2 2016 and update on lixisenatide (Lyxumia/Adlyxin) and iGlarLixi 151
11.3 Other Significant Developments 152
11.3.1 Feb 08, 2017: Dr. Reddys Expands Commercial Operations in Europe 152
11.3.2 Jan 05, 2017: Avadel Pharmaceuticals Provides 2017 Guidance and Business Update 152
11.4 Product News 153
11.4.1 Nov 14, 2016: Aguettants Range of Emergency Injectable Medicine in Ready-to-administer Syringes is Going Global 153
11.5 Strategy And Business Planning 153
11.5.1 Nov 21, 2016: UNITHER Pharmaceuticals opens a Chinese subsidiary: Unither Pharmaceutical Technologies 153
12 Appendix 154
12.1 Research Methodology 155
12.1.1 Coverage 155
12.1.2 Secondary Research 155
12.1.3 Primary Research 156
12.1.4 Company Share Analysis 156
12.1.5 Distribution Share Analysis 156
12.1.6 Benchmarking 157
12.2 GlobalData Consulting 157
12.3 Contact Us 158
12.4 Disclaimer 158

List Of Tables


Table 1: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, 2009-2023 12
Table 2: Drug Delivery Devices Market, France, Category Contribution by Revenue ($m), 2016 14
Table 3: Drug Delivery Devices Market, France, Category Comparison by Revenue ($m), 2009-2023 15
Table 4: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 17
Table 5: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 19
Table 6: Drug Delivery Devices Market, France, Volume (Units), 2009-2023 21
Table 7: Drug Delivery Devices Market, France, Volume (Units), Historic, 2009-2016 23
Table 8: Drug Delivery Devices Market, France, Volume (Units), Forecast, 2016-2023 25
Table 9: Drug Delivery Devices Market, France, Company Share by Revenue ($m), USD Constant, 2016 27
Table 10: Central Venous Catheters Market, France, Segment Contribution (%), 2016 29
Table 11: Central Venous Catheters Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 31
Table 12: Central Venous Catheters Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 33
Table 13: Central Venous Catheters Market, France, Volume (Units), Historic, 2009-2016 35
Table 14: Central Venous Catheters Market, France, Volume (Units), Forecast, 2016-2023 37
Table 15: Central Venous Catheters Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016 38
Table 16: Central Venous Catheters Market, France, Company Share by Revenue ($m), USD Constant, 2016 40
Table 17: Infusion Systems Market, France, Segment Contribution (%), 2016 42
Table 18: Infusion Systems Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 44
Table 19: Infusion Systems Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 46
Table 20: Ambulatory Infusion Pumps Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 48
Table 21: Syringe Pumps Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 50
Table 22: Ambulatory Infusion Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 52
Table 23: Syringe Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 54
Table 24: Infusion Systems Market, France, Volume (Units), Historic, 2009-2016 56
Table 25: Infusion Systems Market, France, Volume (Units), Forecast, 2016-2023 58
Table 26: Ambulatory Infusion Pumps Market, France, Volume (Units), Historic, 2009-2016 60
Table 27: Syringe Pumps Market, France, Volume (Units), Historic, 2009-2016 62
Table 28: Ambulatory Infusion Pumps Market, France, Volume (Units), Forecast, 2016-2023 64
Table 29: Syringe Pumps Market, France, Volume (Units), Forecast, 2016-2023 66
Table 30: Infusion Systems Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016 67
Table 31: Infusion Systems Market, France, Company Share by Revenue ($m), USD Constant, 2016 69
Table 32: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 70
Table 33: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 71
Table 34: Metered Dose Inhaler Devices Market, France, Volume (Units), Historic, 2009-2016 72
Table 35: Metered Dose Inhaler Devices Market, France, Volume (Units), Forecast, 2016-2023 73
Table 36: Metered Dose Inhaler Devices Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016 74
Table 37: Metered Dose Inhaler Devices Market, France, Company Share by Revenue ($m), USD Constant, 2016 76
Table 38: Needle Free Injections Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 77
Table 39: Needle Free Injections Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 78
Table 40: Needle Free Injections Market, France, Volume (Units), Historic, 2009-2016 79
Table 41: Needle Free Injections Market, France, Volume (Units), Forecast, 2016-2023 80
Table 42: Needle Free Injections Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016 81
Table 43: Needle Free Injections Market, France, Company Share by Revenue ($m), USD Constant, 2016 83
Table 44: Drug Delivery Devices Market Pipeline Products 88
Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 93
Table 46: Alimera Sciences Enters into Licensing Agreement with pSivida 95
Table 47: Bluegrass Vascular Enters into Partnership with Merit Medical 96
Table 48: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 97
Table 49: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 98
Table 50: Propeller Health Enters into Agreement with Novartis Pharma 100
Table 51: Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology 101
Table 52: Pfizer Terminates its Licensing Agreement with pSivida 102
Table 53: Biocorp Production Enters into Licensing Agreement 103
Table 54: Bayer Enters into Licensing Agreement with DelSiTech 104
Table 55: BioCorRx Enters into Licensing Agreement with Therakine 105

List Of Figures


Figure 1: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, 2009-2023 11
Figure 2: Drug Delivery Devices Market, France, Revenue Mix ($m), 2016 13
Figure 3: Drug Delivery Devices Market, France, Category Contribution (%), 2016 14
Figure 4: Drug Delivery Devices Market, France, Category Comparison by Revenue ($m), 2009-2023 15
Figure 5: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 16
Figure 6: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 18
Figure 7: Drug Delivery Devices Market, France, Volume (Units), 2009-2023 20
Figure 8: Drug Delivery Devices Market, France, Volume (Units), Historic, 2009-2016 22
Figure 9: Drug Delivery Devices Market, France, Volume (Units), Forecast, 2016-2023 24
Figure 10: Drug Delivery Devices Market, France, Company Share (%) 2016 26
Figure 11: Central Venous Catheters Market, France, Revenue Mix ($m), 2016 28
Figure 12: Central Venous Catheters Market, France, Segment Contribution (%), 2016 29
Figure 13: Central Venous Catheters Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 30
Figure 14: Central Venous Catheters Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 32
Figure 15: Central Venous Catheters Market, France, Volume (Units), Historic, 2009-2016 34
Figure 16: Central Venous Catheters Market, France, Volume (Units), Forecast, 2016-2023 36
Figure 17: Central Venous Catheters Market, France, Company Share (%) 2016 39
Figure 18: Infusion Systems Market, France, Revenue Mix ($m), 2016 41
Figure 19: Infusion Systems Market, France, Segment Contribution (%), 2016 42
Figure 20: Infusion Systems Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 43
Figure 21: Infusion Systems Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 45
Figure 22: Ambulatory Infusion Pumps Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 47
Figure 23: Syringe Pumps Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 49
Figure 24: Ambulatory Infusion Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 51
Figure 25: Syringe Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 53
Figure 26: Infusion Systems Market, France, Volume (Units), Historic, 2009-2016 55
Figure 27: Infusion Systems Market, France, Volume (Units), Forecast, 2016-2023 57
Figure 28: Ambulatory Infusion Pumps Market, France, Volume (Units), Historic, 2009-2016 59
Figure 29: Syringe Pumps Market, France, Volume (Units), Historic, 2009-2016 61
Figure 30: Ambulatory Infusion Pumps Market, France, Volume (Units), Forecast, 2016-2023 63
Figure 31: Syringe Pumps Market, France, Volume (Units), Forecast, 2016-2023 65
Figure 32: Infusion Systems Market, France, Company Share (%) 2016 68
Figure 33: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 70
Figure 34: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 71
Figure 35: Metered Dose Inhaler Devices Market, France, Volume (Units), Historic, 2009-2016 72
Figure 36: Metered Dose Inhaler Devices Market, France, Volume (Units), Forecast, 2016-2023 73
Figure 37: Metered Dose Inhaler Devices Market, France, Company Share (%) 2016 75
Figure 38: Needle Free Injections Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 77
Figure 39: Needle Free Injections Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 78
Figure 40: Needle Free Injections Market, France, Volume (Units), Historic, 2009-2016 79
Figure 41: Needle Free Injections Market, France, Volume (Units), Forecast, 2016-2023 80
Figure 42: Needle Free Injections Market, France, Company Share (%) 2016 82

The report Wine Market in France to 2021 offers the most up-to-date industry data on the actual market situation, and future outlook for wines in France. The research includes historical

View Report

The report Chocolate, Cocoa and Sugar Confectionery Market in France to 2021 offers the most up-to-date industry data on the actual market situation, and future outlook for chocolate, cocoa and

View Report

The report Sugar Market in France to 2021 offers the most up-to-date industry data on the actual market situation, and future outlook for sugar in France. The research includes historical

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports